Analgesic efficacy of celecoxib in postoperative oral surgery pain: A single-dose, two-center, randomized, double-blind, active- and placebo-controlled study

Clinical Therapeutics

Volumn 29, Issue 11 SUPPL. 1, 2007, Pages 2498-2510

  Cheung, Raymond ^a   Krishnaswami, Sriram ^a   Kowalski, Ken ^a  

^a PFIZER INC   (United States)

Author keywords

celecoxib; dental surgery; efficacy; ibuprofen; pain; safety

Indexed keywords

CELECOXIB; IBUPROFEN; PLACEBO;

ADULT; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL SURGERY; PAIN ASSESSMENT; PHYSICAL EXAMINATION; POSTOPERATIVE PAIN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; SINGLE DRUG DOSE; VITAL SIGN; VOMITING;

ADULT; CYCLOOXYGENASE 2 INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; ORAL SURGICAL PROCEDURES; PAIN, POSTOPERATIVE; PYRAZOLES; SULFONAMIDES;

EID: 37349028996     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.12.008     Document Type: Article

References (33)

1. Afzal Z., Esposito M., Well K., et al. Ibuprofen for pain relief after surgical removal of lower wisdom teeth (2003) Publication no. D004488. The Cochrane Database of Systematic Reviews
2. Schafer A. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 35 (1995) 209-219
3. Gabriel S., Jaakkimainen L., and Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115 (1991) 787-796
4. Garcia Rodriguez L., and Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. [published correction appears in Lancet. 1994;343:1048]. Lancet 343 (1994) 769-772
5. Gimbel J., Brugger A., Zhao W., et al. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther 23 (2001) 228-241
6. Ekman E., Wahba M., and Ancona F. Analgesic efficacy of perioperative celecoxib in ambulatory arthroscopic knee surgery: A double-blind, placebo-controlled study. Arthroscopy 22 (2006) 635-642
7. Petrella R., Ekman E., Schuller R., and Fort J. Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: Results of a double-blind, randomized controlled trial. ClinJ Sport Med 14 (2004) 225-231
8. Ekman E., Fiechtner J., Levy S., and Fort J. Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: A multicenter, double-blind, randomized controlled trial in acute ankle sprain. Am J Orthop 31 (2002) 445-451
9. Mehlisch D. A double-blind, placebo-controlled, single-dose comparison of the analgesic activity of SC-58635 25 mg, 50 mg, and 200 mg, ibuprofen 400 mg and placebo in a postsurgical dental pain model (1997), Pfizer Inc, New York, NY Study no. N49-96-02-025
10. Mehlisch D. A double-blind, placebo-controlled, single-dose comparison of the analgesic activity of SC-58635 100 mgand 200 mg, naproxen sodium 550 mg, and placebo in a postsurgical dental pain model (1997), Pfizer Inc, New York, NY Study no. N49-97-02-027
11. Mehlisch D. A double-blind, placebo-controlled, single-dose comparison of the analgesic activity of SC-58635 50 mg, 100 mg, 200 mg, and 400 mg, naproxen sodium 550 mg and placebo in a postsurgical dental pain model (1997), Pfizer Inc, New York, NY Study no. N49-97-02-070
12. Bensen W., Zhao S., Burke T., et al. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo. J Rheumatol 27 (2000) 1876-1883
13. Simon L., Weaver A., Graham D., et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial. JAMA 282 (1999) 1921-1928
14. Moore R., Derry S., Makinson G., and McQuay H. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: Systematic review and meta-analysis of information from company clinical trial reports. [published correction appears in Arthritis Res Ther. 2006;8:401]. Arthritis Res Ther 7 (2005) R644-R665
15. Leese P., Hubbard R., Karim A., et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial. J Clin Pharmacol 40 (2000) 124-132
16. Nikanne E., Kokki H., Salo J., and Linna T. Celecoxib and ketoprofen for pain management during tonsillectomy: A placebo-controlled clinical trial. Otolaryngol Head Neck Surg 132 (2005) 287-294
17. Hegi T., Bombeli T., Seifert B., et al. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth 92 (2004) 523-531
18. Malmstrom K., Daniels S., Kotey P., et al. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active- comparator-controlled clinical trial. Clin Ther 21 (1999) 1653-1663
19. Doyle G., Jayawardena S., Ashraf E., and Cooper S. Efficacy and tolerability of nonprescription ibuprofen versus celecoxib for dental pain. J Clin Pharmacol 42 (2002) 912-919
20. Recart A., Issioui T., White P., et al. The efficacy of celecoxib premedication on postoperative pain and recovery times after ambulatory surgery: A dose-ranging study. Anesth Analg 96 (2003) 1631-1635
21. Celebrex (celecoxib capsules) [prescribing information]. http://www.pfizer.com/pfizer/download/uspi_celebrex.pdf Accessed August 1,2007
22. Reuben S., and Ekman E. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am 87 (2005) 536-542
23. Hubbard R., Naumann T., Traylor L., and Dhadda S. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth 90 (2003) 166-172
24. Nussmeier N., Whelton A., Brown M., et al. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery. Anesthesiology 104 (2006) 518-526
25. Motrin (ibuprofen tablets) [prescribing information]. http://www.pfizer.com/files/products/uspi_motrin.pdf Accessed November 5, 2007
26. Knobloch K., Rossner D., Gossling T., et al. Rhabdomyolysis after administration of diclofenac [in German]. Unfallchirurg 108 (2005) 415-417
27. Delrio F., Park Y., Herzlich B., and Grob D. Case report: Diclofenac-induced rhabdomyolysis. Am J Med Sci 312 (1996) 95-97
28. Nelson H., Katz D., Dunn T., et al. Rhabdomyolysis and necrotic bowel after acetaminophen and ibuprofen overdose. Pharmacotherapy 27 (2007) 608-612
29. Ramachandran S., Giles P., and Hartland A. Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment. BMJ 314 (1997) 1593
30. Montgomery H., Porter J., and Bradley R. Salicylate intoxication causing a severe systemic inflammatory response and rhabdomyolysis. Am J Emerg Med 12 (1994) 531-532
31. Leventhal L., Kuritsky L., Ginsburg R., and Bomalaski J. Salicylate-induced rhabdomyolysis. Am J Emerg Med 7 (1989) 409-410
32. Moneret-Vautrin D., Morisset M., Humbert J., et al. Acetaminophen-induced rhabdomyolysis. Allergy 54 (1999) 1115-1116
33. Riggs J., Schochet Jr. S., and Parmar J. Rhabdomyolysis with acute renal failure and disseminated intravascular coagulation: Association with acetaminophen and ethanol. Mil Med 161 (1996) 708-709